| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 21.4. Miotics and antiglaucoma medicines |
Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (S01ED Beta blocking agents) excluding combinations. |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 09.3.4 Beta Blockers | No observations |
| Cuba | 21.4 Antiglaucomatosos y mióticos | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 21.4. Miotics and antiglaucoma medicines |
Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (S01ED Beta blocking agents) excluding combinations. |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Peru | 21.4 Myotics and Anti-Glaucoma | No observations |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 09.3.4 Beta Blockers | No observations |
| Cuba | 21.4 Antiglaucomatosos y mióticos | No observations |